IP Library Granted Patent US 12,060,605
Granted Patent B2
US 12,060,605 · App. 17/542,345 · Granted Aug 13, 2024

Compositions and methods for nucleic acid sequencing

Inventors: Eli N. Glezer (Del Mar, CA); Mohammad Vatankhah Varnosfaderani (San Marcos, CA); Daan Witters (San Diego, CA); Vahid Karimkhani (San Diego, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6869C12Q1/6844C12Q1/6874G01N33/5308G01N33/544C12Q2533/101C12Q2565/601
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,060,605
App. No.
17/542,345
Filed
Dec 3, 2021
Granted
Aug 13, 2024
Kind
B2
Art Unit
4152
USPC
435/6.11
Abstract

Provided herein are methods and compositions for improved sequencing techniques using, for example, polymeric particles and/or three-dimensional structures.

Claims (26)

1. A composition comprising a plurality of cores surrounded by a shell polymer, wherein:

(a) each core of the plurality of cores is surrounded by the shell polymer;

(b) each core of the plurality of cores is formed by polymerized units of core monomers forming a core polymer;

(c) a core polynucleotide primer is attached to the core polymer;

(d) a target nucleic acid is hybridized to the core primer;

(e) the shell polymer is formed by polymerized units of shell monomers; and

(f) the shell polymer is not attached to a polynucleotide primer.

2. The composition of claim 1 , wherein the core polymer, the shell polymer, or both are a hydrogel.

3. The composition of claim 1 , wherein each core has a core diameter, the shell polymer surrounding each core has a thickness defining an outer shell diameter, and the core diameter is (i) about 20% to about 80% of the outer shell diameter, or (ii) about 50% of the shell diameter.

4. The composition of claim 1 , wherein each core has a core diameter, wherein the shell polymer surrounding each core has a thickness defining an outer shell diameter, and further wherein: (i) the core diameter is about 200-1200 nm, and/or (ii) the shell diameter is about 0.25-5 μm.

5. The composition of claim 1 , wherein the core polynucleotide primer is covalently attached to the core polymer.

6. The composition of claim 1 , wherein the core polymer and shell polymer are permeable to a polymerase.

7. The composition of claim 1 , wherein each core further comprises a silica, magnetic, or paramagnetic bead.

8. The composition of claim 1 , wherein each core further comprises one or more reagents for amplifying the target nucleic acid.

9. The composition of claim 1 , wherein each core further comprises a detectable label that indicates the identity of a nucleotide in the target nucleic acid.

10. The composition of claim 1 , wherein at least some core monomers are the same as at least some of the shell monomers.

11. The composition of claim 1 , wherein the composition comprises a polymer of one or more of GMA (glicydyl methacrylate), HEMA (hydroxyethylmethacrylate), HEA (hydroxyethylacrylate), HPMA (hydroxypropylmethacrylate), polyacrylamide, poly-N-isopropylacrylamide, poly N-isopropylpolyacrylamide, 2-hydroxyethyl acrylate, polyethylene glycol acrylate, and polyethylene glycol methacrylate, or a copolymer thereof.

12. The composition of claim 1 , wherein the core polymer, the shell polymer, or both comprise water.

13. The composition of claim 1 , wherein each core comprises multiple copies of the core polynucleotide primer.

14. The composition of claim 1 , wherein each core comprises multiple copies of the core polynucleotide primer, and about 5-10% of the core monomers in the core polymer of the core are attached to a copy of the core polynucleotide primer.

15. The composition of claim 1 , wherein the shell polymer has a higher permeability than the core polymer.

16. The composition of claim 1 , wherein the composition further comprises a solvent.

17. The composition of claim 16 , wherein the presence of the solvent expands the volume of the composition by up to 90% relative to the absence of the solvent.

18. The composition of claim 1 , wherein the composition is attached to a surface of a solid support.

19. The composition of claim 18 , wherein the solid support is a glass solid support.

20. The composition of claim 18 , wherein the solid support is a flow cell.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2022
From: GLEZER, ELI N.; VARNOSFADERANI, MOHAMMAD VATANKHAH; WITTERS, DAAN; KARIMKHANI, VAHID
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 061743/0758 →
Continuity (4)
Division 17030886 · Sep 24, 2020
Continuation PCTUS2020017060 · Feb 6, 2020
Provisional Application 62802062 · Feb 6, 2019
Related Publication 20220090191A1 · Mar 24, 2022
Cited By (3)
US 12,227,799 US 12,460,261 US 12,680,133